International Journal of Bipolar Disorders
Overview
International Journal of Bipolar Disorders is a scientific journal, published since 2013 in English. The journal's country of origin is Germany.
Details
Details
Abbr.
Int J Bipolar Disord
Start
2013
End
Continuing
Frequency
Monthly
e-ISSN
2194-7511
Country
Germany
Language
English
Metrics
Metrics
h-index / Ranks: 9569
35
SJR / Ranks: 2484
1298
CiteScore / Ranks: 2677
7.30
JIF / Ranks: 2264
4.0
Recent Articles
1.
Stanislaus S, Coello K, Kjaerstad H, Sletved K, Miskowiak K, Faurholt-Jepsen M, et al.
Int J Bipolar Disord
. 2025 Mar;
13(1):10.
PMID: 40080331
Background: Oxidative stress may be involved in the pathophysiology of bipolar disorder (BD). Malondialdehyde (MDA), a product of fatty acid peroxidation has been proposed as a trait marker of BD...
2.
Anke T, Skjelstad D
Int J Bipolar Disord
. 2025 Feb;
13(1):9.
PMID: 39992465
Background: The postpartum period is associated with a high risk of illness episodes in women with bipolar disorder (BD) and is a critical developmental phase for both a new mother...
3.
Storosum B, Cohen S, Steinz C, Mattila T, Welten C, van den Brink W, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):8.
PMID: 39988647
Background: Little is known about the effect of ethnicity on drug treatment in patients with an acute manic episode. The aim of this study is to determine whether ethnicity moderates...
4.
Glaus J, Karow A, Lambert M, Sowada P, Brockel-Bundt K, Berndt C, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):7.
PMID: 39964389
Background: Improving quality of life (QoL) is important for the treatment of people with bipolar disorder (BD). Early-BipoLife is a German multicentre naturalistic, prospective-longitudinal observational cohort study investigating early recognition...
5.
Renes J, Kupka R, Nolen W, Have M, van der Markt A, Boks M, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):6.
PMID: 39955418
Background: Little attention has been paid to the generalizability of cohort studies in bipolar disorder (BD) to patient with BD in everyday clinical practice. Methods: A sample of patients with...
6.
Javier A, Jaworska N, Fiedorowicz J, Magnotta V, Richards J, Barsotti E, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):4.
PMID: 39953335
Background: Approximately half of people with bipolar disorder type I (BD-I) report the presence of psychotic symptoms at least at some point during their illness. Previous data suggest that more...
7.
Aiff H, Attman P, Golic M, Ramsauer B, Schon S, Steingrimsson S, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):5.
PMID: 39953220
Objectives: To study the prospects for lithium treated patients who develop end stage renal disease (ESRD) and the role of renal replacement therapy (RRT). Methods: Retrospective analysis of survival, somatic...
8.
Greil W, de Bardeci M, Nievergelt N, Erfurth A, Hasler G, Bridler R, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):3.
PMID: 39945975
Background: Global pharmacoepidemiological evidence suggests dynamically changing prescription patterns in patients with bipolar disorders. We assessed trends in the use of pharmacological agents used in the management of bipolar disorders...
9.
Khan S, Shah D, Yadav G, Mansuri Z, Jain S
Int J Bipolar Disord
. 2025 Jan;
13(1):2.
PMID: 39884977
No abstract available.
10.
van der Aa M, Bonenkamp A, Klumpers U, Kupka R, Nijenhuis T, Kerckhoffs A
Int J Bipolar Disord
. 2025 Jan;
13(1):1.
PMID: 39760940
Background: A surrogate marker (a substitute indicator of the true outcome) is needed to predict subgroups of long-term lithium users at risk of end-stage kidney disease (ESKD). In this narrative...